NSE › Healthcare

COHANCE (COHANCE)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹425.35+0.07%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹619 cr
Revenue YoY
+54.0%
Net profit
₹20 cr
Profit YoY
-53.5%
EPS
₹0.55
EPS estimate
₹3.18
Net margin
3.2%

EPS came in at 0.55 against a street estimate of 3.18 — a miss of 82.7%.

Key statistics

Market cap
₹16,394 cr
P/E
91.6
Forward P/E
22.4
P/B
4.16
Book value
₹102.03
EPS (TTM)
₹4.68
52-week high
₹1,038.90
52-week low
₹266.70
50-day MA
₹435.60
200-day MA
₹442.88
Beta
0.56

Analyst view

with an average price target of ₹514.00.

Shareholding

Promoters
63.97%
Institutions
24.46%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for COHANCE — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.